{"database": "lobbying", "table": "lobbying_activities", "rows": [[2504870, "021b2eed-d518-402d-bbc7-c5784b195f2f", "Q3", "LANTHEUS HOLDINGS, INC.", 401105198, "LANTHEUS HOLDINGS, INC.", 2020, "third_quarter", "MMM", "HR 3772 Medicare Diagnostic Radiopharmaceutical Equity Act; and\nOnshoring Pharmaceutical Manufacturing", "Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE", null, 35000, 0, 0, "2020-10-07T21:00:09.017000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2504870"], "units": {}, "query_ms": 27.073509991168976, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}